Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
A concise checklist to verify inputs, validate assumptions, and confirm your zero based budget remains aligned with priorities.
17,617 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
A once-bleeding-edge EV player shows measurable progress: rising revenue, better vehicle margins, smaller losses, and...
A little-known AI infrastructure stock last year exploded 14x, shaking up investors who focus on AI chips. This artic...
When a MongoDB director sells a sizable block of shares, investors pause to weigh the meaning. This article breaks do...
Tired of guessing what to charge for your Airbnb? This practical playbook shows you how to price with data, test stra...
In a land of hype cycles and volatile headlines, a strong cash-flow machine can outlast the fiercest cannabis hype. T...
A major headline sent Goldman Sachs stock popping, tied to reports it could lead SpaceX's mega-IPO. This article brea...
When a biotech stock jumps after a conference, investors want to know if it’s sustainable. This article breaks down w...
Oruka stock has surged dramatically, propelled by momentum and speculation. A substantial insider sale adds another l...
When mining stocks move, gold prices often lead the dance. This article breaks down why coeur mining stock dropped, w...
Wednesday brought an outsized move for Sprinklr as earnings beat and optimism around CXM services spurred fresh buyin...
Canopy Growth has slipped while the market rose. This article breaks down the reasons behind the drop, what it means ...